The increasing prevalence of Metabolic syndrome (MetS) is a worldwide health problem,
and the association between MetS and skin diseases has recently attracted growing …

Abstract Background and Aim Metabolic syndrome (MetS) is a well‐known
noncommunicable disease that plays a significant role in emerging other chronic disorders …

Metabolic syndrome (Met S) is a clustering of risk factors comprising of abdominal obesity,
dyslipidemia, elevated blood pressure, and abnormal glucose tolerance. The prevalence of …

There is ongoing scientific interest regarding comorbidities associated with the metabolic
syndrome (MeTS). MeTS comprises a combination of parameters that predispose …

In medical practice, almost every clinician may encounter patients with skin disease.
However, it is not always easy for physicians of all specialties to face the daily task of …

Obesity is widely recognized as an epidemic in the Western world; however, the impact of
obesity on the skin has received minimal attention. The purpose of this article is to highlight …

Psoriasis is an immune-mediated systemic disease with associated comorbidities, including
metabolic syndrome (MetS) which contributes substantially to premature mortality in patients …

Psoriasis (PS) is an incessant, fiery skin sickness characterized by erythematous plaques
with thick silvery scales, white or red patches of the skin, which encompasses several …

The association of the metabolic syndrome (MetS) and its components with immune-
mediated chronic inflammatory disorders has attracted much interest within the last two …

Obesity is a worldwide major public health problem with an alarmingly increasing
prevalence over the past 2 decades. The consequences of obesity in the skin are …